DUBLIN, Ireland, Nov. 04, 2016 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in November:
Global Mizuho Investment Conference
- Date: November 14, 2016
- Location: New York, NY
Stifel Healthcare Conference
- Date: November 15, 2016
- Presentation Time: 8:45 a.m. EST
- Location: New York, NY
Jefferies Autumn 2016 Global Healthcare Conference
- Date: November 17, 2016
- Presentation Time: 1:20 p.m. GMT
- Location: London, United Kingdom
Bank of America Leveraged Finance Conference
- Date: November 29, 2016
- Presentation Time: 7:30 a.m. EST
- Location: Miami, FL
Piper Jaffray Healthcare Conference
- Date: November 29, 2016
- Presentation Time: 8 a.m. EST
- Location: New York, NY
For the above conferences with presentations, they will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcasts will be available for the events with presentations.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. Horizon Pharma markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts: Tina Ventura Senior Vice President, Investor Relations [email protected] U.S. Media: Geoff Curtis Senior Vice President, Corporate Communications [email protected] Ireland Media: Ray Gordon Gordon MRM [email protected]


Shell M&A Chief Exits After BP Takeover Proposal Rejected
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 



